Literature DB >> 33941393

COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic.

Khan Sharun1, Kuldeep Dhama2.   

Abstract

The wealthy countries have already secured 60% of the total coronavirus disease (COVID-19) vaccine supplies for their citizens. Some of these countries have pre-ordered vaccine doses sufficient enough to vaccinate their population multiple times. India has recently initiated a diplomatic mission named "Vaccine Maitri" to provide COVID-19 vaccine doses to needy low-income countries. The ability of the country to manufacture cost-effective vaccines along with the ability to export large vaccine consignments worldwide will help to meet the global COVID-19 vaccine requirements. Furthermore, global vaccination coverage can only be achieved by ensuring equitable access to COVID-19 vaccines.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Vaccination coverage; Vaccine; Vaccine diplomacy

Year:  2021        PMID: 33941393     DOI: 10.1016/j.arcmed.2021.04.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  10 in total

Review 1.  Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario.

Authors:  T K Suvvari; C P; S Kuppili; V Kandi; L V S Kutikuppala; V D K Kandula; S Mishra; A K Sarangi; R K Mohapatra; K Dhama
Journal:  Arch Razi Inst       Date:  2021-11-30

2.  Aggressive behaviour of anti-vaxxers and their toxic replies in English and Japanese.

Authors:  Kunihiro Miyazaki; Takayuki Uchiba; Kenji Tanaka; Kazutoshi Sasahara
Journal:  Humanit Soc Sci Commun       Date:  2022-07-05

3.  Recommendation and Roadmap of Mass Vaccination against Coronavirus Disease 2019 Pandemic in Bangladesh as a Lower-Middle-Income Country.

Authors:  M J Hossain; S M A Rahman; T B Emran; S Mitra; M R Islam; K Dhama
Journal:  Arch Razi Inst       Date:  2021-12-30

4.  COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns.

Authors:  Khan Sharun; Ruchi Tiwari; Kuldeep Dhama; Ali A Rabaan; Saad Alhumaid
Journal:  Hum Vaccin Immunother       Date:  2021-07-22       Impact factor: 4.526

Review 5.  A comprehensive review on efficient approaches for combating coronaviruses.

Authors:  Mahdi Pouresmaieli; Elena Ekrami; Ali Akbari; Negin Noorbakhsh; Negin Borzooee Moghadam; Matin Mamoudifard
Journal:  Biomed Pharmacother       Date:  2021-10-22       Impact factor: 6.529

6.  Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines.

Authors:  Md Jamal Hossain; Ali A Rabaan; Abbas Al Mutair; Saad Alhumaid; Talha Bin Emran; G Saikumar; Saikat Mitra; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-02-16       Impact factor: 3.452

Review 7.  COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges.

Authors:  Kuldeep Dhama; Manish Dhawan; Ruchi Tiwari; Talha Bin Emran; Saikat Mitra; Ali A Rabaan; Saad Alhumaid; Zainab Al Alawi; Abbas Al Mutair
Journal:  Hum Vaccin Immunother       Date:  2022-03-08       Impact factor: 4.526

8.  4 COVID-19 Ds to remember when approaching Monkeypox.

Authors:  Aparajeya Shanker; Christos Tsagkaris
Journal:  Ann Med Surg (Lond)       Date:  2022-09-01

9.  Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.

Authors:  Victoria Pilkington; Sarai Mirjam Keestra; Andrew Hill
Journal:  Front Public Health       Date:  2022-03-07

10.  Omicron (B.1.1.529) variant of SARS-CoV-2: Concerns, challenges, and recent updates.

Authors:  Ranjan K Mohapatra; Ruchi Tiwari; Ashish K Sarangi; Md Rabiul Islam; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-02-12       Impact factor: 20.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.